{"id":"ab-1002","safety":{"commonSideEffects":[{"rate":null,"effect":"Muscle weakness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"AB-1002 uses a viral vector to deliver the healthy gene to the target cells, replacing the faulty gene and potentially restoring normal function. This approach has shown promise in treating genetic diseases caused by mutations in a single gene.","oneSentence":"AB-1002 is a gene therapy that aims to treat certain genetic disorders by delivering a healthy copy of the gene.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:28:07.399Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of Duchenne muscular dystrophy"}]},"trialDetails":[{"nctId":"NCT05598333","phase":"PHASE2","title":"Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"AskBio Inc","startDate":"2023-10-20","conditions":"Congestive Heart Failure","enrollment":150},{"nctId":"NCT04179643","phase":"PHASE1","title":"AB-1002 in Patients With Class III Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"AskBio Inc","startDate":"2019-11-20","conditions":"Congestive Heart Failure, Heart Failure, Heart Disease, Ischemic","enrollment":17}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Gene Therapy","NAN-101"],"phase":"phase_2","status":"active","brandName":"AB-1002","genericName":"AB-1002","companyName":"AskBio Inc","companyId":"askbio-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AB-1002 is a gene therapy that aims to treat certain genetic disorders by delivering a healthy copy of the gene. Used for Treatment of Duchenne muscular dystrophy.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}